To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Arsenal Capital Partners-backed CellCarta buys Biogazelle
Montreal-based CellCarta, formerly Caprion-HistoGeneX, has acquired Biogazelle, a Ghent, Belgium-based specialist in applications to support pharmaceutical research, clinical trials and diagnostic test development.
